Dynamic quantitative monitoring of cerebrospinal fluid monoamine neurotransmitter markers during the modeling process of chronic stress-induced depression in monkeys (Macaca mulatta)
- PMID: 39169445
- PMCID: PMC11338840
- DOI: 10.1002/brb3.3636
Dynamic quantitative monitoring of cerebrospinal fluid monoamine neurotransmitter markers during the modeling process of chronic stress-induced depression in monkeys (Macaca mulatta)
Abstract
Background: Depression is known as the "mental cold" and is also considered a major cause of disability worldwide. It is estimated that over 300 million people worldwide suffer from severe depression, equivalent to 4.4% of the world's population. The monoamine hypothesis of depression predicts the underlying pathophysiological mechanisms of depression, but in-depth research has failed to find convincing evidence.
Method: In this study, we will dynamically and strictly quantitatively monitor the concentration changes of monoamine transmitters in the cerebrospinal fluid (CSF) of macaques, based on our previous work. In the experiment, timed and quantitative collection of CSF samples from macaques was performed and the concentration of monoamine transmitters was determined.
Result: The results showed that after 2 months of chronic stress, the concentrations of high vanillin acid (HVA) and 3,4-dihydroxy-phenylacetic acid were significantly higher in the maternal separation (MS) group, whereas there was no significant difference in dopamine and 5-hydroxyindoleacetic acid.
Conclusion: This study is the first to observe the long-term dynamic relationship between early adversity, chronic stress, adolescent depression, and CSF monoamine concentrations. The research suggests that MS and chronic stress play an undeniable role in the pathogenesis of depression and that concentrations of HVA and dihydroxyphenylacetic acid are likely to serve as early markers of depressive-like symptoms in macaques.
Keywords: chronic stress; depression; early adversity; monoamine transmitters.
© 2024 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




References
-
- Aberg‐Wistedt, A. , Alvariza, M. , Bertilsson, L. , Malmgren, R. , & Wachtmeister, H. (1985). Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldine. Acta Psychiatrica Scandinavica, 71, 256–268. - PubMed
-
- Argyelán, M. , Szabó, Z. , Kanyó, B. , Tanács, A. , Kovács, Z. , Janka, Z. , & Pávics, L. (2005). Dopamine transporter availability in medication free and in bupropion treated depression: A 99mTc‐TRODAT‐1 SPECT study. Journal of Affective Disorders, 89, 115–123. - PubMed
-
- Asim, M. , Wang, H. , & Waris, A. (2023). Altered neurotransmission in stress‐induced depressive disorders: The underlying role of the amygdala in depression. Neuropeptides, 98, 102322. - PubMed
MeSH terms
Substances
Grants and funding
- 202001BC070001/Natural Science Foundation of Yunnan Province
- 202102AA100053/Natural Science Foundation of Yunnan Province
- 202101AY070001-001/Kunming Medical Joint Project-Key Project
- 2018FE001(-135)/Yunnan Provincial Science and Technology Department
- 2018FE001(-307)/Yunnan Provincial Science and Technology Department
LinkOut - more resources
Full Text Sources
Medical